Document is current
Any future updates will be listed below
-
Authors
Tarkiainen, Maarit http://orcid.org/0000-0002-1569-5349
Tynjälä, Pirjo
Vähäsalo, Paula
Aalto, Kristiina
Kröger, Liisa
Rebane, Katariina
Lahdenne, Pekka
Martikainen, Janne
-
Funding
Funding for this research was provided by:
Lastentautien Tutkimussäätiö
Suomen Lääketieteen Säätiö
- License Information
-
More Information
Article History
Received: 16 June 2022
Accepted: 25 September 2022
First Online: 16 November 2022
Declarations
:
: This trial was primarily registered with the Ethical Board of Helsinki District University Hospital (ExternalRef removed), clinical trial number 211 864, and later with ClinicalTrials.gov, number NCT01015547. A written informed consent was obtained from the patients or their families.
: Not applicable.
: PV reports non-financial support from Abbvie, and Novartis; personal fees and non-financial support from Pfizer, MSD, Sobi, and Roche, outside the submitted work; JM is a founding partner of ESiOR Oy and a board member of Siltana Oy. These companies were not involved in carrying out this research. Other authors have nothing to declare.
